Literature DB >> 23464883

Successful autologous cord blood transplantation in a child with acquired severe aplastic anemia.

David Buchbinder1, Loah Hsieh, Geetha Puthenveetil, Amit Soni, Jill Stites, Van Huynh, Ivan Kirov, Steve Neudorf, Elyssa Rubin, Leonard Sender, Lilibeth Torno, David Margolis, Richard Childs, Theodore Moore, Diane Nugent.   

Abstract

Over 400 cases of pediatric SAA occur annually in the United States. A growing number of children with SAA may have had their stem cells harvested through cord blood collection. We describe a nine-yr-old male with SAA treated successfully with an autologous cord blood transplant following immunoablative chemotherapy. With the increasing number of people cryopreserving autologous cord blood, the use of autologous cord blood in the treatment of SAA might be considered as initial therapy. This case serves to discuss approaches to preparative therapy as well as the potential complications in this growing cohort of patients.
© 2013 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23464883      PMCID: PMC4174564          DOI: 10.1111/petr.12068

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  20 in total

1.  Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia.

Authors:  Judith C Marsh; Vikas Gupta; Ziyi Lim; Aloysius Y Ho; Robin M Ireland; Janet Hayden; Victoria Potter; Mickey B Koh; M Serajul Islam; Nigel Russell; David I Marks; Ghulam J Mufti; Antonio Pagliuca
Journal:  Blood       Date:  2011-04-25       Impact factor: 22.113

2.  Acceptable HLA-mismatching in unrelated donor bone marrow transplantation for patients with acquired severe aplastic anemia.

Authors:  Hiroshi Yagasaki; Seiji Kojima; Hiromasa Yabe; Koji Kato; Hisato Kigasawa; Hisashi Sakamaki; Masahiro Tsuchida; Shunichi Kato; Takakazu Kawase; Yasuo Morishima; Yoshihisa Kodera
Journal:  Blood       Date:  2011-07-14       Impact factor: 22.113

Review 3.  Hematopoietic cell transplantation with autologous cord blood in patients with severe aplastic anemia: an opportunity to revisit the controversy regarding cord blood banking for private use.

Authors:  Joseph Rosenthal; Ann E Woolfrey; Anna Pawlowska; Sandra H Thomas; Frederick Appelbaum; Stephen Forman
Journal:  Pediatr Blood Cancer       Date:  2011-03-02       Impact factor: 3.167

4.  Infusion of autologous peripheral blood stem cells in an unrelated donor who developed severe aplastic anemia following stem cell donation.

Authors:  H Frangoul; W H Navarro; D L Confer; M Jagasia
Journal:  Bone Marrow Transplant       Date:  2011-08-29       Impact factor: 5.483

5.  Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience.

Authors:  Sujith Samarasinghe; Colin Steward; Prashant Hiwarkar; Muhammad Ameer Saif; Rachael Hough; David Webb; Alice Norton; Sarah Lawson; Amrana Qureshi; Philip Connor; Peter Carey; Rod Skinner; Ajay Vora; Maria Pelidis; Brenda Gibson; Graham Stewart; Steve Keogh; Nick Goulden; Denise Bonney; Mathew Stubbs; Persis Amrolia; Kanchan Rao; Stefan Meyer; Rob Wynn; Paul Veys
Journal:  Br J Haematol       Date:  2012-02-29       Impact factor: 6.998

6.  Autologous transplant in the treatment of severe aplastic anemia--a case report.

Authors:  Bela Balint; Dragana Stamatovic; Milena Todorovic; Marija Elez; Danilo Vojvodic; Mirjana Pavlovic; Milica Cucuz-Jokic
Journal:  Transfus Apher Sci       Date:  2011-08-25       Impact factor: 1.764

7.  Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.

Authors:  Jakub Tolar; H Joachim Deeg; Sally Arai; Mitchell Horwitz; Joseph H Antin; John M McCarty; Roberta H Adams; Marian Ewell; Eric S Leifer; Iris D Gersten; Shelly L Carter; Mary M Horowitz; Ryotaro Nakamura; Michael A Pulsipher; Nancy L Difronzo; Dennis L Confer; Mary Eapen; Paolo Anderlini
Journal:  Biol Blood Marrow Transplant       Date:  2012-04-27       Impact factor: 5.742

8.  High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up.

Authors:  Robert A Brodsky; Allen R Chen; Donna Dorr; Ephraim J Fuchs; Carol Ann Huff; Leo Luznik; B Douglas Smith; William H Matsui; Steven N Goodman; Richard F Ambinder; Richard J Jones
Journal:  Blood       Date:  2009-12-16       Impact factor: 22.113

Review 9.  Autologous stem cell transplantation in autoimmune diseases.

Authors:  Jakob Passweg; Alan Tyndall
Journal:  Semin Hematol       Date:  2007-10       Impact factor: 3.851

10.  Clinical observations on intensive immunosuppressive therapy combined with umbilical cord blood support for the treatment of severe aplastic anemia.

Authors:  Fang Zhou; Linfu Ge; Zhe Yu; Yuan Fang; Fansheng Kong
Journal:  J Hematol Oncol       Date:  2011-06-10       Impact factor: 17.388

View more
  1 in total

Review 1.  Acquired aplastic anemia in children.

Authors:  Helge D Hartung; Timothy S Olson; Monica Bessler
Journal:  Pediatr Clin North Am       Date:  2013-10-16       Impact factor: 3.278

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.